Absence of glutamic acid decarboxylase antibodies in childhood epilepsies

Pediatric Neurology

Volumn 21, Issue 5, 1999, Pages 794-796

  Rantala, Heikki ^a   Kulmala, Petri ^a   Savola, Kaisa ^a   Knip, Mikael ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUTAMATE DECARBOXYLASE; PREDNISONE;

ABSENCE; ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; ENZYME ACTIVITY; EPILEPSY; FRONTAL LOBE EPILEPSY; GENERALIZED EPILEPSY; HUMAN; IMMUNOASSAY; INFANT; INFANTILE SPASM; INSULIN DEPENDENT DIABETES MELLITUS; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MYOCLONUS EPILEPSY; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; THERAPY RESISTANCE;

ANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE;

EID: 0032698591     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00088-0     Document Type: Article

References (19)

1. Bu D.F., Erlander M.G., Hitz B.C., et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A. 89:1992;2115-2119.
2. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem. 56:1991;720-723.
3. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol. 44:1998;194-201.
4. Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark A., Baekkeskov S. Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia. 31:1988;597-602.
5. Atkinson M.A., Maclaren N.K., Scharp D.W., Lacy P.E., Riley W.J. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet. 335:1990;1357-1360.
6. Sigurdsson E., Baekkeskov S. The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol. 164:1990;143-168.
7. Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med. 322:1990;1555-1560.
8. Saiz A., Arpa J., Sagasta A., et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology. 49:1997;1026-1030.
9. Nemni R., Braghi S., Natalisora M.G., et al. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol. 36:1994;665-667.
10. Giometto B., Nicolao P., Macucci M., Tavolato B., Foxon R., Bottazzo G.F. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet. 352:1998;457.
11. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 30:1989;389-399.
12. Bonifacio E., Genovese S., Braghi S., et al. Islet autoantibody markers in IDDM Risk assessment strategies yielding high sensitivity . Diabetologia. 38:1995;816-822.
13. Savola K., Sabbah E., Kulmala P., Vähäsalo P., Ilonen J., Knip M. Autoantibodies associated with type 1 diabetes mellitus persist after diagnosis in children. Diabetologia. 41:1998;1293-1297.
14. Verge CF, Stenger D, Bonifacio E, et al., for the Combinatorial Islet Autoantibody Workshop. Combined use of autoantibodies (IA-2) autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Diabetes 1998;47:1857-66.
15. Hrachovy R.A., Frost J.D. Jr, Pollack M.S., Glaze D.G. Serologic HLA typing in infantile spasms. Epilepsia. 29:1988;817-819.
16. van Engelen B.G., Weemaes C.M., Renier W.O., Bakkeren J.A., Borm G.F., Strengers P.F. A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand J Immunol. 41:1995;209-213.
17. Riikonen R., Donner M. ACTH therapy in infantile spasms Side effects . Arch Dis Child. 55:1980;664-672.
18. Ariizumi M., Shiihara H., Hibio S., et al. High dose gammaglobulin for intractable childhood epilepsy. Lancet. 2:1983;162-163.
19. Dambinova S.A., Izykenova G.A., Burov S.V., Grigorenko E.V., Gromov S.A. The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy. J Neurol Sci. 152:1997;93-97.